inflammatory pathways targeted in the pathophysiology of ibd: clinical trial results
Published 4 years ago • 905 plays • Length 16:40Download video MP4
Download video MP3
Similar videos
-
12:48
ibd clinical update: new and emerging targeted therapies
-
28:54
treat to target in ibd
-
26:14
mechanisms of disease: unraveling the small molecule pipeline for ibd
-
23:44
mechanisms of disease: biologic pipeline for ibd
-
17:44
implementing treatment pathways for the management of ulcerative colitis and crohn's disease
-
23:55
new biologic therapies that target the il-12/23 pathway
-
20:09
targeting the il-12/23 pathway in ibd
-
21:36
how will future therapeutic pathways change for ulcerative colitis and crohn's disease?
-
21:36
keynote: evolution of disease management in ibd
-
10:50
treat-to-target in ibd: decreasing inflammation & achieving mucosal healing
-
28:12
current and evolving therapeutic landscape of ibd
-
22:05
understanding the use of il12/il23 targeted biologics
-
20:05
ibd pathogenesis: personalizing targets
-
17:23
evolving approaches to ibd management: from step-care to treat-to-target
-
27:21
inflammatory bowel disease and pregnancy
-
37:14
investigator insights: clinical trial endpoints and ibd indices in clinical practice
-
16:48
new therapies that target the jak-stat pathway and other small molecules
-
6:22
antibiotics and risk of new onset inflammatory bowel disease: a meta-analysis
-
27:12
evaluating and treating pain in ibd